Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section with Texas as the study site. The page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:27:17.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added and Revision: v3.2.0 has been removed, a minor metadata update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:54:33.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed. The page previously warned that information may be out of date due to a lapse in government funding.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:57.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Only minor administrative updates are visible on the page, including the latest update date and minor layout tweaks. The core study details—eligibility criteria, enrollment numbers, study design, and primary/secondary outcomes—appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:51.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:34:19.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:25:51.000Z thumbnail image

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.